Follicle Stimulating Hormone Market Opportunities, Future Plans, Competitive Landscape and Growth by Forecast 2034
In 2024, the global Follicle Stimulating Hormone (FSH) market was valued at approximately USD 2.2 billion, reflecting its growing significance in reproductive health and fertility treatments worldwide. With rising infertility rates and advancements in hormone therapy, the market is expected to reach USD 3.8 billion by 2034, expanding at a CAGR of 7.1% over the forecast period. The growth trajectory is supported by the increased adoption of Assisted Reproductive Technology (ART), greater patient awareness, and expanding access to fertility care.